PharmaCyte Biotech to Present at H.C. Wainwright BioConnect Conference
LAS VEGAS–(BUSINESS WIRE)– PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it will be featured as a presenting company at the H.C. Wainwright BioConnect Conference. The Conference is being held virtually on January 10-13, 2022. During
Read more →